Michael A. Sullivan

Attorney Profile

Top Rated Employment & Labor Attorney in Atlanta, GA

Finch McCranie, LLP
 | 1700 South Tower, 225 Peachtree Street, NE
Atlanta, GA 30303
Phone: 404-658-9070
Fax: 404-688-0649
Selected To Super Lawyers: 2006 - 2020
Licensed Since: 1985
Practice Areas:
  • Employment & Labor: Employee (30%),
  • Securities Litigation (40%),
  • Health Care (30%)
    Attorney Profile

    Michael A. Sullivan is a former federal prosecutor who has more than thirty years of experience in sophisticated civil and criminal litigation. He represents whistleblowers in qui tam litigation under the False Claims Act, in the SEC Whistleblower and CFTC Whistleblower Programs, and in the IRS Whistleblower Program.

    Mr. Sullivan has worked with the False Claims Act since the late 1980s and has both defended and prosecuted cases under the False Claims Act. Mr. Sullivan helped draft Georgia’s two False Claims Act statutes, the 2007 “State False Medicaid Claims Act,” and the 2012 “Georgia Taxpayer Protection False Claims Act.” Since the December 2006 beginning of the new IRS Whistleblower Program, Mr. Sullivan has also represented IRS whistleblowers in submissions totaling billions of dollars. He has also worked with the IRS Whistleblower Office staff in presenting programs on best practices in pursuing IRS Whistleblower claims.

    In 2009 and again in 2010, Mr. Sullivan was contacted and consulted by staff members of the U.S. Senate Banking Committee to discuss how the whistleblower provisions of the new "Dodd-Frank" law should be written, and how the new SEC and CFTC Whistleblower Programs should operate. In 2011, he met with the SEC and CFTC Chairmen and senior staff to recommend changes to the proposed rules for SEC and CFTC Whistleblower claims. Since then, he has also represented clients in the SEC Whistleblower and CFTC Whistleblower Programs.

    Mr. Sullivan represented Relators in two of the most significant health care fraud qui tam recoveries in recent years: (1) the $465 million settlement by Mylan, Inc. in 2017 for erroneously classifying its patented, brand name drug EpiPen as a generic drug to avoid its obligation to pay higher Medicaid rebates; and (2) the groundbreaking case that authorized use of statistical sampling to prove elements of FCA liability and damages, United States ex rel. Glenda Martin v. Life Care Centers of America, Inc. (E.D. TN), which in 2016 produced the largest health care fraud settlement in history against a skilled nursing facility chain. He also created and chairs the annual “Whistleblower Law Symposium,” a national program to educate lawyers on developments in the False Claims Act, the SEC Whistleblower and CFTC Whistleblower Programs, and the IRS Whistleblower Program.

    Mr. Sullivan also currently serves on the Senior Leadership Team of the Volkswagen AG Monitorship, as counsel to Larry D. Thompson in Mr. Thompson’s role as the Independent Compliance Monitor and Auditor of Volkswagen AG, and as counsel to the VW Monitor Team. Mr. Sullivan’s responsibilities include coordinating with counsel across the globe to advise on legal requirements of countries in Europe, Asia, North America, and South America.

    Mr. Sullivan graduated from The University of North Carolina at Chapel Hill with a Bachelor of Arts in 1977. In 1984, he received his Juris Doctor from Vanderbilt University Law School, where he was Senior Articles Editor of the Vanderbilt Law Review.

     
    Practice Areas
    • 30%Employment & Labor
    • 40%Securities Litigation
    • 30%Health Care
    Focus Areas

    Whistleblower

    Selections

    Selected to Super Lawyers for 15 yearsbottom-image

    Super Lawyers: 2006 - 2020

    Email Me

    To: Michael A. Sullivan
    Super Lawyers: Potential Client Inquiry

    About Michael Sullivan

    Admitted: 1985, Georgia

    Professional Webpage: https://www.finchmccranie.com/michael-a-sullivan.html

    Honors/Awards:

    • Senior Articles Editor, Vanderbilt Law Review, Vanderbilt University Law School

    Bar/Professional Activity:

    • In 2011, Mr. Sullivan met with the SEC and CFTC Chairmen and senior staff to recommend changes to the proposed rules for SEC and CFTC Whistleblower claims. Since then, he has also represented clients in the SEC Whistleblower and CFTC Whistleblower Programs., 2011
    • Mr. Sullivan represented Relators in two of the most significant health care fraud qui tam recoveries in recent years: (1) the $465 million settlement by Mylan, Inc. in 2017 for erroneously classifying its patented, brand name drug EpiPen as a generic drug to avoid its obligation to pay higher Medicaid rebates; and (2) the groundbreaking case that authorized use of statistical sampling to prove elements of FCA liability and damages, United States ex rel. Glenda Martin v. Life Care Centers of America, Inc. (E.D. TN), which in 2016 produced the largest health care fraud settlement in history against a skilled nursing facility chain.
    • Mr. Sullivan also currently serves on the Senior Leadership Team of the Volkswagen AG Monitorship, as counsel to Larry D. Thompson in Mr. Thompson’s role as the Independent Compliance Monitor and Auditor of Volkswagen AG, and as counsel to the VW Monitor Team. Mr. Sullivan’s responsibilities include coordinating with counsel across the globe to ensure complaince with legal requirements of countries in Europe, Asia, North America, and South America.
    • In 2009 and again in 2010, Mr. Sullivan was contacted and consulted by staff members of the U.S. Senate Banking Committee to discuss how the whistleblower provisions of the new "Dodd-Frank" law should be written, and how the new SEC and CFTC Whistleblower Programs should operate.
    • Chair, Whistleblower Law Symposium--a national program that addresses latest developments in whistleblower law with leading experts.  Recent topics include fraud in cryptocurrencies/digital currencies, trends in False Claims Act enforcement, and best practices in pursuing claims in the SEC Whistleblower Program, CFTC Whistleblower Program, and IRS Whistleblower Program.  Mr. Sullivan created this program more than ten years ago.

    Scholarly Lectures/Writings:

    • Regularly updated summary of the False Claims Act., Author, “The Federal False Claims Act and Georgia's Two State False Claims Acts” (2007-2019)., 2019

    Verdicts/Settlements:

    • Mr. Sullivan represented Relators in two of the most significant health care fraud qui tam recoveries in recent years: (1) the $465 million settlement by Mylan, Inc. in 2017 for erroneously classifying its patented, brand name drug EpiPen as a generic drug to avoid its obligation to pay higher Medicaid rebates; and (2) the groundbreaking case that authorized use of statistical sampling to prove elements of FCA liability and damages, United States ex rel. Glenda Martin v. Life Care Centers of America, Inc. (E.D. TN), which in 2016 produced the largest health care fraud settlement in history against a skilled nursing facility chain., 2017

    Representative Clients:

    • Mr. Sullivan serves on the Senior Leadership Team of the Volkswagen AG Monitorship, as counsel to Larry D. Thompson in Mr. Thompson’s role as the Independent Compliance Monitor and Auditor of Volkswagen AG, and as counsel to the VW Monitor Team. Mr. Sullivan’s responsibilities include coordinating with counsel across the globe to comply with legal requirements of countries in Europe, Asia, North America, and South America.

    Educational Background:

    • University of North Carolina

    Industry Groups

    • CFTC Whistleblower Claims
    • False Claims Act (Qui Tam) Litigation
    • IRS Whistleblower claims
    • SEC Whistleblower Claims
    Show More
    Office Location for Michael A. Sullivan

    1700 South Tower
    225 Peachtree Street, NE
    Atlanta, GA 30303

    Phone: 404-658-9070

    Fax: 404-688-0649

    Michael A. Sullivan:

    Last Updated: 11/11/2019

    Page Generated: 0.13236808776855 sec